Canada markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
42.56+1.70 (+4.16%)
At close: 04:00PM EDT
42.50 -0.06 (-0.14%)
After hours: 06:33PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-141,429
-141,429
-112,325
-70,511
-59,780
Depreciation & amortization
3,008
3,008
2,896
3,068
3,929
Deferred income taxes
0
0
0
-227
-1,167
Stock based compensation
23,890
23,890
15,611
8,953
3,915
Change in working capital
13,462
13,462
-3,898
-1,054
-299
Other working capital
-109,109
-109,109
-105,560
-62,158
-41,956
Other non-cash items
-
-
-6,862
-1,405
-4,218
Net cash provided by operating activites
-107,291
-107,291
-103,732
-60,909
-40,404
Cash flows from investing activities
Investments in property, plant and equipment
-1,818
-1,818
-1,828
-1,249
-1,552
Purchases of investments
-424,561
-424,561
-188,965
-389,881
-220,321
Sales/Maturities of investments
320,597
320,597
280,666
174,947
123,600
Other investing activites
-
-
69
27
55
Net cash used for investing activites
-105,782
-105,782
89,942
-216,156
-98,218
Cash flows from financing activities
Debt repayment
-
-
0
0
-2,962
Common stock issued
216,222
216,222
0
269,893
170,792
Net cash used privided by (used for) financing activities
218,458
218,458
4,076
272,372
171,226
Net change in cash
5,385
5,385
-9,714
-4,693
32,604
Cash at beginning of period
29,429
29,429
39,143
43,836
11,232
Cash at end of period
34,814
34,814
29,429
39,143
43,836
Free Cash Flow
Operating Cash Flow
-107,291
-107,291
-103,732
-60,909
-40,404
Capital Expenditure
-1,818
-1,818
-1,828
-1,249
-1,552
Free Cash Flow
-109,109
-109,109
-105,560
-62,158
-41,956